Cannabis and glaucoma: the short answer
Smoked or vaporized cannabis can lower intraocular pressure (IOP) for about three to four hours. Clinical studies published through 2025 still do not show that this effect prevents vision loss from glaucoma. The American Academy of Ophthalmology and the American Glaucoma Society both advise against cannabis as a glaucoma treatment, and no cannabis product has FDA approval for the condition.
Medical Cannabis for Glaucoma: Reviews, Risks, and Comparison
Why eye pressure matters in glaucoma
Glaucoma damages the optic nerve, often before a person notices any change in sight. Raised IOP is the main risk factor doctors can modify. Prescription drops, laser therapy, and surgery hold pressure down through the full 24-hour cycle. A treatment that lowers pressure for three hours and then wears off leaves the optic nerve exposed the rest of the day.
medical cannabis for glaucoma near me card
What the clinical studies measured
- Smoking or vaporizing THC-rich flower lowered IOP by about 25% to 30% in several small trials, with the drop starting within 30 to 60 minutes.
- The effect faded within three to four hours, and repeated use produced tolerance within days.
- Oral and sublingual cannabinoids produced weaker and less predictable pressure drops than inhaled forms.
- One small trial in healthy adults found CBD raised IOP rather than lowering it.
- A National Academies review found substantial evidence for short-term IOP reduction and insufficient evidence that cannabinoids treat glaucoma itself.
What 2025 research adds
Recent work has shifted toward topical delivery and receptor targeting instead of smoked flower. Laboratory and early human studies look at cannabinoid eye drops, selective CB1 and CB2 agonists, nanoemulsions, and compounds aimed at protecting the optic nerve rather than only dropping pressure. Some researchers now frame cannabinoids as a possible neuroprotective add-on, not a replacement for pressure-lowering therapy. Most of these studies remain small, use short follow-up, and have not reached phase 3 trials. As of 2025, no cannabinoid eyedrop is on the market for glaucoma.
medical marijuana for glaucoma symptoms relief
Why a joint will not replace your drops
Cannabis also lowers systemic blood pressure. When blood pressure drops, perfusion to the optic nerve can drop with it, which may work against the goal of protecting that nerve. Heavy, frequent use adds respiratory and cognitive risks, and driving or working while impaired is a real hazard. To match the coverage of a single daily prostaglandin drop, a person would need to dose every three hours, including overnight. That schedule is not realistic for most patients.
medical marijuana for glaucoma symptoms relief
How to check a cannabis glaucoma claim
- Find the original study and note whether it measured IOP or actual vision loss.
- Check the sample size and how long participants were followed.
- Note the delivery method: smoked, vaporized, oral, sublingual, or topical.
- Look for a control group and confirmation that the work passed peer review.
- Ask your ophthalmologist whether the finding would change your current treatment plan.
What to discuss with your eye doctor
Keep using prescribed drops or scheduled procedures. Tell your eye doctor about any cannabis use, because it can interact with blood pressure medications, affect anesthesia, and complicate surgical planning. If you use cannabis for sleep, pain, or appetite, say so. Your doctor can then watch your pressures and adjust treatment without guessing.
Bottom line
The evidence for cannabis in glaucoma is limited to a brief pressure drop that does not last long enough to protect the optic nerve. Clinical research in 2025 is exploring topical cannabinoids and neuroprotection, but nothing has replaced standard care. Buy cannabis for the effects you enjoy, not as a substitute for glaucoma treatment.